Skip to content

Hansen Gwenn

Reporting owner on Forms 3, 4 and 5, CIK 1817160.

Hansen Gwenn reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-02.

Issuers

IssuerRoles in the latest filingFilingsLast filed
NRIX · Nurix Therapeutics, Inc.CIK 1549595officer (Chief Scientific Officer)22026-11-02

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
NRIX · Nurix Therapeutics, Inc.Common Stock2026-11-02M exercised+1,452$1.86124,904Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-11-02S sold-1,452$26.8123,452Form 4
NRIX · Nurix Therapeutics, Inc.Employee Stock Option (right to buy), derivative2026-11-02M exercised-1,452$057,954Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-30M exercised+3,750$0120,977Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-30M exercised+2,859$0123,836Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-30M exercised+3,573$0127,409Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-30S sold-3,957$26.2791123,452Form 4
NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative2026-10-30M exercised-3,750$07,500Form 4
NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative2026-10-30M exercised-2,859$017,150Form 4
NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative2026-10-30M exercised-3,573$035,730Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-15M exercised+1,452$1.86118,679Form 4
NRIX · Nurix Therapeutics, Inc.Common Stock2026-10-15S sold-1,452$25117,227Form 4
NRIX · Nurix Therapeutics, Inc.Employee Stock Option (right to buy), derivative2026-10-15M exercised-1,452$059,406Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001817160-26-000023 Nurix Therapeutics, Inc.2026-11-02
Form 4 0001817160-26-000021 Nurix Therapeutics, Inc.2026-10-15